Skip to content

US · OACC · SHELL COMPANIES

Oaktree Acquisition Corp. II (OACC) intrinsic value and stock valuation

$10.70as of 2026-09-18 · Mkt cap 265M

Data updated · price as of 2026-09-18

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Oaktree Acquisition Corp. II DCF and intrinsic value

InvestorsCraft values OACC with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from OACC’s statements →

Oaktree Acquisition Corp. II Graham Number

Graham Number: $9,309,531.32d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Financial Services · Shell Companies Los Angeles, CA, US oaktreeacquisitioncorp.com

How the business is doing

Fiscal 2025–2024, USD

Revenue
$0.00
20252024
Net income
$2.66B
20252024
Free cash flow
-$-179M
20252024
Total equity
$187.5T
20252024

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2025–2024, USD
FYFY
Revenue$0.00$0.00
Operating income-$-1.2T-$-703M
Net income$7.29T$2.66B
EPSd$379.6K$108.33
Operating cash flow-$-422.08B-$-179M
Capital expenditure$0.00-$-3M
Free cash flow-$-422.08B-$-179M
Total assets$203.1T$195.3T
Total debt$11.8B$11.8B
Net debt-$-1.42T-$-1.35T
Total equity$194.8T$187.5T
Cash and short-term investments$1.43T$1.36T
Income statement
FYFY
Revenue$0.00$0.00
Cost of revenue$0.00$0.00
Gross profit$0.00$0.00
Research and development expenses$0.00$0.00
Selling, general and administrative expenses$1.2T$703.6M
Other expenses$0.00$0.00
Operating expenses$1.2T$703.6M
Cost and expenses$1.2T$703.6M
Interest income$8.48T$1.59T
Interest expense$0.00$0.00
Depreciation and amortization$0.00$703.6M
Ebitda-$-1.2T-$-351.81B
Operating income-$-1.2T-$-703M
Total other income/expenses, net$8.48T$3.37B
Income before tax$7.29T$2.66B
Income tax expense$0.00$0.00
Net income$7.29T$2.66B
Weighted average shares outstanding$19.2T$24.6T
Weighted average diluted shares outstanding$19.2T$24.6T
Balance sheet
FYFY
Cash and short-term investments$1.43T$1.36T
Net receivables$0.00$0.00
Inventory$0.00$0.00
Total current assets$1.55T$1.56T
Property, plant and equipment, net$0.00$0.00
Goodwill and intangible assets$0.00$0.00
Long-term investments$201.6T$193.6T
Total non-current assets$201.6T$193.7T
Total assets$203.1T$195.3T
Accounts payable$0.00$0.00
Short-term debt$11.8B$11.8B
Deferred revenue$0.00$0.00
Total current liabilities$1.3T$727.3B
Long-term debt$0.00$0.00
Deferred revenue, non-current$0.00$0.00
Total non-current liabilities$7.02T$7.02T
Capital lease obligations$0.00$0.00
Total liabilities$8.32T$7.75T
Common stock$201.6T$193.6T
Retained earnings-$-6.77T-$-6.08T
Accumulated other comprehensive income (loss)$0.00$0.00
Total equity$194.8T$187.5T
Total investments$201.6T$193.6T
Total debt$11.8B$11.8B
Net debt-$-1.42T-$-1.35T
Cash flow statement
FYFY
Net income$7.29T$2.66B
Depreciation and amortization$0.00$0.00
Stock-based compensation$0.00$0.00
Change in working capital$773.6B-$-629M
Accounts receivable$0.00$0.00
Inventory$0.00$0.00
Accounts payable-$-33.55B$0.00
Net cash provided by operating activities-$-422.08B-$-89.69B
Investments in property, plant and equipment$0.00$0.00
Acquisitions, net$0.00$0.00
Net cash used for investing activities$500B-$-191.99T
Common stock issued$0.00$194T
Common stock repurchased$0.00$0.00
Dividends paid$0.00$0.00
Net cash used for financing activities$0.00$193.4T
Net change in cash$77.9B$1.36T
Cash at end of period$1.43T$1.36T
Operating cash flow-$-422.08B-$-179M
Capital expenditure$0.00-$-3M
Free cash flow-$-422.08B-$-179M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Oaktree Acquisition Corp. II

        Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

        CEO
        Zaid Pardesi
        Employees
        3
        Beta
        -0.04

        Explore

        Frequently asked questions

        What is the intrinsic value of Oaktree Acquisition Corp. II (OACC)?

        InvestorsCraft does not currently publish an intrinsic value for OACC. How the IC value is calculated.

        Is OACC undervalued?

        InvestorsCraft does not publish an undervaluation signal for OACC at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Sep 19, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.